Clinical Trial Update: Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating autologous stem cell transplant using Th2/Tc2 cells for advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms | Phase 1 | Status: COMPLETED